Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Oncotarget|April 15, 2015
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerInès Dufait, Julia Katharina Schwarze, Therese Liechtenstein, et al.
Journal of Virology|January 30, 2009
Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapyKatarzyna Karwacz, Sayandip Mukherjee, Luis Apolonia, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 13, 2019
Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoringMarta Barrado, Idoia Blanco-Luquin, Paola Andrea Navarrete, et al.
Oncotarget|April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracersKatrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
International Journal of Molecular Sciences|August 23, 2020
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade ImmunotherapyAna Bocanegra, Ester Blanco, Gonzalo Fernandez-Hinojal, et al.
International Journal of Molecular Sciences|April 5, 2020
Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor TherapiesCarlos Hernandez, Hugo Arasanz, Luisa Chocarro, et al.
The Journal of Gene Medicine|January 30, 2016
Lentiviral expression of GAD67 and CCK promoter-driven opsins to target interneurons in vitro and in vivoLaura Mantoan Ritter, Douglas C Macdonald, Georg Ritter, et al.
Pageof 10